BDBM50208611 (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-4H-chromen-4-one::CHEMBL243148::sophoraflavanone G

SMILES [#6]\[#6](-[#6])=[#6]\[#6]-[#6@H](-[#6]-c1c(-[#8])cc(-[#8])c2-[#6](=O)-[#6]-[#6@H](-[#8]-c12)-c1ccc(-[#8])cc1-[#8])-[#6](-[#6])=[#6]

InChI Key InChIKey=XRYVAQQLDYTHCL-CMJOXMDJSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50208611   

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Homo sapiens (Human))
University of Toyama

Curated by ChEMBL
LigandPNGBDBM50208611((2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)...)
Affinity DataIC50:  1.00E+3nMAssay Description:Inhibition of human CaV3.1 expressed in HEK293 cells assessed as suppression of T-current after 10 mins by whole cell patch clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed